Company Search:
Advanced Search
Sponsored Links
InMed Pharmaceuticals Inc Company Snapshot
InMed Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares InMed Pharmaceuticals Inc with three other pharmaceutical manufacturers in North America: Stromacel Inc of UNITED STATES (2011 sales of $26,004.00 of which 100% was Sperm Bank), GT Biopharma Inc of UNITED STATES ($26,000.00 of which 100% was Health & Pharmaceutical), and Cellular Biomedicine Group Inc which is also based in UNITED STATES ($35,500.00 ).

Sales Analysis. InMed Pharmaceuticals Inc reported sales of C$38,410.00 (US$28.12 thousand) for the fiscal year ending June of 2011. This represents a sharp decrease of 54.1% versus 2010, when the company's sales were C$83,763.00 .
  Stock Performance Chart for InMed Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/26/2020): .28
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks -16.4%  
4 Weeks 16.7%   52 Weeks -15.2%  
InMed Pharmaceuticals Inc Key Data:
  Ticker: IN Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2011 Sales 38,410
(Year Ending Jan 2012).
Employees: 12
  Currency: Canadian Dollars Market Cap: 48,239,417
  Fiscal Yr Ends: June Shares Outstanding: 172,283,633
  Share Type: Closely Held Shares: 1,265,225
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.